Skip to main content
Pfizer COVID-19 vaccine appointments are available to our patients.
Sign up for Connect today
to schedule your vaccination.
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Joint Clinical Trials Office
Explore this Website
Home
About
Toggle About menu options
News
JCTO Contacts
Careers
Our Clinical Trial Locations
Partner with the JCTO
Toggle Partner with the JCTO menu options
JCTO Fees
Open Clinical Trials
Investigators
Patients
Toggle Patients menu options
What is a Clinical Trial?
Frequently Asked Questions
Clinical Trial Questions to Ask Your Healthcare Team
Clinical Trials: Common Terms to Know
Understanding Clinical Trials and How They Work
Understanding Clinical Trials - In Spanish | En Español
Weill Cornell Medicine
Care
Discover
Teach
Home
About
Open Clinical Trials
Investigators
Patients
Home
Clinical Trials
The WCM Advancing HIV Health through Epigenetic studies in Aging and Alzheimer's Disease (AHEAD) Study
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 11, 2023
Feasibility and Acceptability of a Mobile Cognitive Behavior Therapy App Targeting Depression and Anxiety in Middle Aged and Older Adults
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 11, 2023
Inflammatory Skin Disease Treatment Identification Study (IDENTITY)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 16, 2023
Assessing the effect of abstinence period on semen analysis parameters
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 17, 2023
UA COVID-19 National Registry: National Registry of Pediatric Cancer Patients Diagnosed with COVID-19
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
Phase II Study of Olaparib (AZD2281) in Patients with Metastatic/Advanced Urothelial Carcinoma and Other Genitourinary Tumors with DNA-Repair Defects
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
Pilot Study of DS-8201a Pharmacodynamics in Patients with HER2-expressing Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
A Phase 1 Study of Lenalidomide in Combination with EPOCH Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma (ATLL)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
Randomized Phase 2 Clinical Trial of Nab-paclitaxel + Durvalumab (MEDI4736) + Tremelimumab + Neoantigen Vaccine vs. Nab-paclitaxel + Durvalumab (MEDI4736) + Tremelimumab in Patients with Metastatic Triple Negative Breast Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
Phase 1/1B Study of DS-8201a in Combination with ATR Inhibition (AZD6738) in Advanced Solid Tumors with HER2 Expression (DASH Trial)
Study Status:
Open to Enrollment
Primary Investigator:
Date:
May 23, 2023
« first
‹ previous
…
13
14
15
16
17
(current)
18
19
20
21
…
next ›
last »